37
Participants
Start Date
February 28, 2024
Primary Completion Date
December 30, 2028
Study Completion Date
December 30, 2029
Sacituzumab Govitecan
"* 4 cycles, each cycle lasting for 3 weeks~* 10mg/kg given every day 1 and day 8 each cycle~* IV infusion"
Pembrolizumab
"* 4 cycles, each cycle lasting for 3 weeks in Neoadjuvant phase; after surgery, 13 cycles, each cycle lasting for 3 weeks in Maintenance phase.~* 200mg fixed dose every day 1 each cycle~* IV infusion"
RECRUITING
Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong
RECRUITING
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
RECRUITING
Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong
RECRUITING
Department of Oncology, Princess Margaret Hospital, Hong Kong
Chinese University of Hong Kong
OTHER